Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 1863 entries
View as:

A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00131898 Org: User:
Start: 05/31/03 End: 09/30/05 Due: 09/30/06

Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00142571 Org: User:
Start: 01/31/03 End: 09/30/07 Due: 09/30/08

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Phase: N/A Priority: Normal
NCT ID: NCT05787574 Org: User:
Start: 03/15/23 End: 03/31/27 Due: 03/31/28

Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00561756 Org: User:
Start: 10/31/07 End: 11/30/15 Due: 11/30/16

Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00605670 Org: User:
Start: 06/30/05 End: 11/30/13 Due: 11/30/14

Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Phase: N/A Priority: Normal
NCT ID: NCT02099097 Org: User:
Start: 03/24/14 End: 12/24/20 Due: 12/24/21

Sleep in Hospitalized Children at MSKCC

Phase: N/A Priority: Normal
NCT ID: NCT02836041 Org: User:
Start: 07/07/16 End: 05/26/21 Due: 05/26/22

Radiation Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002480 Org: User:
Start: 02/28/91 End: 08/31/05 Due: 08/31/06

Group Interventions for Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01775085 Org: User:
Start: 01/31/13 End: 01/31/26 Due: 01/31/27

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03643510 Org: User:
Start: 08/21/18 End: 08/31/26 Due: 08/31/27

A Registry for People With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06424327 Org: User:
Start: 05/15/24 End: 05/15/29 Due: 05/15/30

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT05184816 Org: User:
Start: 12/22/21 End: 12/31/25 Due: 12/31/26

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01261728 Org: User:
Start: 12/14/10 End: 12/31/25 Due: 12/31/26

A Study of Exercise Therapy in People With Solid Tumor Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06597786 Org: User:
Start: 09/12/24 End: 09/30/27 Due: 09/30/28

Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older

Phase: N/A Priority: Normal
NCT ID: NCT02647190 Org: User:
Start: 01/31/16 End: 06/30/17 Due: 06/30/18

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00014495 Org: User:
Start: 11/30/00 End: 12/31/09 Due: 12/31/10

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

Phase: N/A Priority: Normal
NCT ID: NCT00578409 Org: User:
Start: 05/31/04 End: 04/30/10 Due: 04/30/11

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05657873 Org: User:
Start: 12/09/22 End: 12/09/25 Due: 12/09/26

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Phase: N/A Priority: Normal
NCT ID: NCT05736419 Org: User:
Start: 02/09/23 End: 02/09/26 Due: 02/09/27

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01189643 Org: User:
Start: 08/31/10 End: 08/31/25 Due: 08/31/26

A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04743362 Org: User:
Start: 02/02/21 End: 08/02/31 Due: 08/02/32

Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00847015 Org: User:
Start: 02/28/09 End: 11/30/12 Due: 11/30/13

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00014482 Org: User:
Start: 12/31/00 End: 03/31/03 Due: 03/31/04

Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03300284 Org: User:
Start: 08/07/17 End: 07/13/23 Due: 07/13/24

Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03159117 Org: User:
Start: 05/16/17 End: 01/10/20 Due: 01/10/21